Cargando…

Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?

Detalles Bibliográficos
Autores principales:	Badagliacca, Roberto, D’Alto, Michele, Ghio, Stefano, Vizza, Carmine Dario, Naeije, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885839/ https://www.ncbi.nlm.nih.gov/pubmed/33105086 http://dx.doi.org/10.1164/rccm.202010-3834LE

Ejemplares similares

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

Comment on Topyła-Putowska et al. Echocardiography in Pulmonary Arterial Hypertension: Comprehensive Evaluation and Technical Considerations. J. Clin. Med. 2021, 10, 3229
por: Manzi, Giovanna, et al.
Publicado: (2022)

The Growing Role of Echocardiography in Pulmonary Arterial Hypertension Risk Stratification: The Missing Piece
por: Miotti, Cristiano, et al.
Publicado: (2021)

Reply to Kamp et al.: Novel Insight into Pulmonary Fibrosis and Long Covid
por: Hatabu, Hiroto, et al.
Publicado: (2023)

Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
por: Velásquez, Gustavo E., et al.
Publicado: (2019)

Reply to Gagnon et al.: Video Teleheath and Pulmonary Rehabilitation: Need for a Better Understanding
por: Bhatt, Surya P., et al.
Publicado: (2020)

Reply to Chen et al.: BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
por: Provencher, Steeve, et al.
Publicado: (2020)

Reply to Lescoat et al. and to Khamis et al.
por: Adegunsoye, Ayodeji, et al.
Publicado: (2019)

Reply to Chase et al. and to Milner et al.
por: Mittel, Aaron M., et al.
Publicado: (2020)

Reply by Xu et al. to Haouzi et al.
por: Xu, Yonghao, et al.
Publicado: (2020)

Reply by Pan et al. to Haouzi et al.
por: Pan, Chun, et al.
Publicado: (2020)

Reply to Topeli et al. and to Akinosoglou et al.
por: Azevedo, Luciano C. P., et al.
Publicado: (2020)

Reply to Turnbull et al. and to Hulme et al.
por: Breuer, Oded, et al.
Publicado: (2020)

Reply to Shoemark et al. and to Shapiro et al.
por: Amirav, Israel, et al.
Publicado: (2020)

Reply to Gueret et al. and to Hammond et al.
por: Brown, Ryan M., et al.
Publicado: (2020)

Reply to Blot et al. and to Inoue et al.
por: McElvaney, Oliver J., et al.
Publicado: (2021)

Reply to Sanfilippo et al. and to Caviedes et al.
por: Arachchillage, Deepa J., et al.
Publicado: (2021)

Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)

Reply to Nie et al. and Bhammar et al.
por: Peters, Michael C., et al.
Publicado: (2022)

Reply to Fillatre et al. and Li et al.
por: Abdul-Aziz, Mohd H., et al.
Publicado: (2022)

Reply to Prieto-Centurion et al.: Patients with Chronic Obstructive Pulmonary Disease Require More Than Pulmonary Rehabilitation to Improve Outcomes
por: Nici, Linda, et al.
Publicado: (2019)

Reply to Mahler et al.: Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Nici, Linda, et al.
Publicado: (2020)

Reply to Ning et al.: More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension
por: Provencher, Steeve, et al.
Publicado: (2020)

Reply to Kobayashi et al.: Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kondoh, Yasuhiro, et al.
Publicado: (2020)

Reply to Kuek et al.: Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease
por: Burgel, Pierre-Régis, et al.
Publicado: (2021)

Reply to Sun et al.: circGASP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
por: Sun, Yuan-Yuan, et al.
Publicado: (2021)

THARYAN ET AL REPLY
por: Tharyan, Prathap, et al.
Publicado: (1994)

THARYAN ET AL'S REPLY
por: Tharyan, Prathap
Publicado: (1995)

Reply to Pawar et al
por: Todd, Stacy, et al.
Publicado: (2014)

Reply to Farmakiotis et al
por: Waddington, Claire S., et al.
Publicado: (2014)

Reply to Cunnington et al
por: Hanson, Josh, et al.
Publicado: (2013)

Reply to Yates et al
por: Middelkoop, Keren, et al.
Publicado: (2015)

Reply to Goyal et al
por: Hsiang, Michelle S., et al.
Publicado: (2015)

Reply to Worth et al
por: Mitchell, Brett G., et al.
Publicado: (2014)

Reply to Boyd et al
por: Solomon, Marc M., et al.
Publicado: (2015)

Reply to Sauvage et al
por: Desnues, Christelle, et al.
Publicado: (2014)

Reply to Thysen et al
por: Tchakoute, Christophe Toukam, et al.
Publicado: (2015)

Reply to Rossi et al
por: Hsiang, Michelle S, et al.
Publicado: (2017)

Reply to Dian et al
por: Thao, Le Thi Phuong, et al.
Publicado: (2018)

Reply to Kempf et al
por: Thorne, L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rc5bunrpg0c2r50rs46us0obip